Neuromarkers which can predict neurodevelopmental impairment among children with congenital heart defects after cardiac surgery: A systematic literature review

Dev Neurorehabil. 2023 Apr;26(3):206-215. doi: 10.1080/17518423.2023.2166618. Epub 2023 Jan 29.

Abstract

The aim of this systematic literature review was to assess the data regarding neuromarkers used to evaluate the impact of cardiovascular surgery on neurodevelopmental pattern of children with congenital heart defects. A systematic search was performed on PubMed and Google Scholar databases. Out of 713 publications screened, 10 studies (471 patients) met the inclusion criteria. The included studies were coded on several variables: number and heterogeneity of patients (age, congenital heart defects), exclusion of patients with conditions that predispose to neurological impairment, neuroimaging workup pre- and post-surgery, neurodevelopmental assessment, interventions (part of a different study), and follow-up period. Results were reported according to PRISMA guidelines. Findings include: neuron-specific enolase and brain-derived neurotrophic factor are not reliable neuromarkers, for protein S100B different results were reported, for activin A there is lack of evidence, and glial fibrillary acidic protein could represent a reliable neuromarker for acute brain-injury. Directions for future research are discussed.

Keywords: Congenital heart defect; S100 protein; brain-derived neurotrophic factor; glial fibrillary acidic protein; neuron-specific enolase.

Publication types

  • Systematic Review

MeSH terms

  • Biomarkers
  • Brain Injuries*
  • Cardiac Surgical Procedures* / adverse effects
  • Child
  • Heart Defects, Congenital* / surgery
  • Humans
  • Neuroimaging

Substances

  • Biomarkers